MDMA ("ecstasy") impairs learning in the Morris Water Maze and reduces hippocampal LTP in young rats

Neuroscience Letters

Volumn 469, Issue 3, 2010, Pages 375-379

  Arias Cavieres, Alejandra ^a,d   Rozas, Carlos ^a   Reyes Parada, Miguel ^a   Barrera, Nelson ^b   Pancetti, Floria ^c   Loyola, Sebastian ^a   Lorca, Ramón A ^a   Zeise, Marc L ^a   Morales, Bernardo ^a  

^a UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSIDAD CATÓLICA DEL NORTE   (Chile)

^d UNIVERSIDAD DE VALPARAÍSO   (Chile)

Author keywords

Hippocampus; MDMA; Synaptic plasticity; Visuo spatial learning

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; LEARNING DISORDER; LONG TERM POTENTIATION; MALE; MAZE TEST; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL;

AGING; ANIMALS; CA1 REGION, HIPPOCAMPAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; LONG-TERM POTENTIATION; MALE; MAZE LEARNING; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURONAL PLASTICITY; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SPACE PERCEPTION; SWIMMING; TIME FACTORS; VISUAL PERCEPTION;

EID: 73649099089     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.12.031     Document Type: Article

References (32)

1. Able J., Gudelsky G., Vorhees C., and Williams M.T. 3,4-Methylenedioxy-methamphetamine in adult rats produces deficits in path integration and special reference memory. Biol. Psychiatry 59 (2006) 1219-1226
2. ACMD Advisory Council on the Misuse of Drugs, MDMA ('ecstasy'): a review of its harms and classification under the Misuse of Drugs Act 1971, 2009. http://drugs.homeoffice.gov.uk/publication-search/acmd/mdma-report.
3. 3H]paroxetine-labeled serotonin uptake sites. J. Pharmacol. Exp. Therap. 242 (1987) 911-916
4. Capela J.P., Carmo H., Remião F., Bastos M.L., Meisel A., and Carvalho F. Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol. Neurobiol. 39 (2009) 210-227
5. Dommett E.J., Henderson E.L., Westwell M.S., and Greenfield S.A. Methylphenidate amplifies long-term plasticity in the hippocampus via noradrenergic mechanisms. Learn. Memory 15 (2008) 580-586
6. Escubedo E., Camarasa J., Chipana C., García-Ratés S., and Pubill D. Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications. Int. Rev. Neurobiol. 88 (2009) 121-166
7. Green R., Mechan A., Elliot M., O'Shea E., and Colado M.I. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"). Pharmacol. Rev. 55 (2003) 463-508
8. Gudelsky G.A., and Yamamoto B.K. Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons. Pharmacol. Biochem. Behav. 90 (2008) 198-207
9. Herlenius E., and Lagercrantz H. Development of neurotransmitter systems during critical periods. Exp. Neurol. 190 (2004) S8-S21
10. Higuchi M., Suzuki Y., Yatani Y., Kitagawa Y., Nagayasu K., Shirakawa H., Nakagawa T., and Kaneko S. Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons. J. Neurochem. 106 (2008) 2410-2420
11. Mordenti J., and Chappell W. The use of interspecies scaling in toxicokinetics. In: Yacobi A., Kelly J., and Batra V. (Eds). Toxicokinetics in New Drug Development (1989), Pergamon Press, New York 42-96
12. Morris R.G.M., Garrund P., Rawlins J.N.P., and O'Keefe J.O. Place navigation impaired in rats with hippocampal lesions. Nature 297 (1982) 681-683
13. National Drug Intelligence Center, National Drug Threat Assessment 2009, Document ID: 2008-Q0317-005, 2009. http://www.justice.gov/ndic/pubs31/31379/.
14. O'Shea E., Granados R., Esteban B., Colado M., and Green A. The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). Neuropharmacology 37 (1998) 919-926
15. Parrott A.C. Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or ecstasy. J. Psychopharmacol. 19 (2005) 71-83
16. Reyes-Parada M., Scorza M., Silveira R., Dajas F., Costa G., Tipton K., and Cassels B. Monoamine oxidase inhibitory effects of some 4-p-aminophenethylamine derivatives. Biochem. Pharmacol. 47 (1994) 1365-1371
17. Rogers G., Elston J., and Garside R. The harmful health effects of recreational ecstasy: a systematic review of observational evidence. Health Technol. Assess. 13 (2009) 1-338
18. Romano A.G., and Harvey J.A. MDMA enhances associative and non-associative learning in the rabbit. Pharmacol. Biochem. Behav. 47 (1993) 289-293
19. Rozas C., Frank H., Heynen A.J., Morales B., Bear M.F., and Kirkwood A. Developmental inhibitory gate controls the relay of activity to the superficial layers of the visual cortex. J. Neurosci. 21 (2001) 6791-6801
20. Rozas C., Pancetti F., Reyes-Parada M., Cassels B., and Morales B. MDMA facilitate the long-term potentiation but not long-term depression in CA1 of hippocampus. Annual Meeting of the Society for Neuroscience. Washington D.C., USA (2008) (abstract P737)
21. Scholey A.B., Parrott A.C., Buchanan T., Heffernan T.M., Ling J., and Rodgers J. Increased intensity of ecstasy and polydrug usage in the more experienced recreational ecstasy/MDMA users. Addict. Behav. 29 (2004) 743-752
22. Sprague J., Preston A., Leifheit M., and Woodside B. Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning. Physiol. Behav. 79 (2003) 281-287
23. Torres G.E., Gainetdinov R.R., and Caron M.G. Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev. Neurosci. 4 (2003) 13-25
24. Trigo J.M., Cabrero-Castel A., Berrendero F., Maldonado R., and Robledo P. MDMA modifies active avoidance learning and recall in mice. Psychopharmacology 197 (2008) 391-400
25. Vorhees C., Reed T., Skelton M., and Williams M. Exposure to 3,4 methylenedioxymethamphetamine (MDMA) on postnatal days 11-20 induces reference but not working memory deficits in Morris water maze in rats: implications of prior learning. Int. J. Dev. Neurosci. 22 (2004) 247-259
26. Vorhees C., and Williams M. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 1 (2006) 848-858
27. Vorhees C., Schaefer T., and Williams M. Developmental effects of ±3,4 methylenedioxymethamphetamine on spatial versus path integration learning: effects of dose distribution. Synapse 61 (2007) 488-499
28. Vorhees C., Schaefer T., Skelton M., Grace C., Herring N., and Williams M. (+/-) 3,4 methylenedioxymethamphetamine (MDMA) dose-dependently impairs spatial learning in the Morris water maze after exposure of rats to different five-day intervals from birth to postnatal day twenty. Dev. Neurosci. -Basel 31 (2009) 107-120
29. Whitlock J., Heynen A., Shuler M., and Bear M. Learning induces long-term potentiation in the hippocampus. Science 313 (2006) 1093-1097
30. Winsauer P.J., Quinton M.S., Porter J.R., Corll C.B., Moerschbaecher J.M., Delatte M.S., Leonard S.T., and Stroble S.B. Effects of MDMA administration on scopolamine-induced disruptions of learning and performance in rats. Pharmacol. Biochem. Behav. 79 (2004) 459-472
31. Zakzanis K.K., Campbell Z., and Jovanovski D. The neuropsychology of ecstasy (MDMA) use: a quantitative review. Hum. Psychopharmacol. 22 (2007) 427-435
32. Zeise M.L., Espinoza S., González A., Cerda F.S., Nacarate J., Yáñez C.G., and Morales B. Methylphenidate improves cue navigation in the Morris water maze in rats. NeuroReport 18 (2007) 1059-1062